Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMPIN vs RILUZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMPIN vs RILUZOLE: Safety Overview

Metric RIFAMPIN RILUZOLE
Total FAERS Reports 13,347 1,437
Deaths Reported 1,439 342
Death Rate 10.8% 23.8%
Hospitalizations 5,764 264
Average Patient Age 51.7 yrs 63.5 yrs
% Female Patients 47.8% 47.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Aug 22, 2024
Manufacturer Hikma Pharmaceuticals USA Inc. EDW PHARMA
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued